Collaborating Centers of Excellence in Regulatory Science and Innovation (U01)
As part of FDA's Advancing Regulatory Science Initiative, the Office of the Chief Scientist supports innovation aimed at development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products.This funding opportunity will provide support
for one or more Centers of Excellence in Regulatory Science and Innovation (CERSIs), which will serve to advance the Agency's regulatory science goals through cutting-edge research, state-of -the-art training/educational programs and collaborative interactions including scientific exchanges, workshops and seminars.This Funding Opportunity Announcement (FOA) will provide support, depending on availability of FDA funding, for:
1) competing continuation of existing CERSIs and 2) establishment of one or more new CERSIs.
1) competing continuation of existing CERSIs and 2) establishment of one or more new CERSIs.
Who's Eligible
Obtain Full Opportunity Text:
Full Announcement of RFA-FD-16-036
Additional Information of Eligibility:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.
Full Opportunity Web Address:
Contact:
Agency Email Description:
Agency Email:
eric.bozoian@fda.hhs.gov
Date Posted:
2016-04-25
Application Due Date:
2016-06-28
Archive Date:
2016-07-24
Social Entrepreneurship
Spotlight
Rwanda as Social Entrepreneur Fund Beneficiary
The Republic of Rwanda has been picked as one of the six African countries as beneficiaries for a new fellowship fund program designed at supporting social entrepreneurs in tackling issues on food security.
Learn How to Identify and Avoid Grant Scams
